Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
Published on: April 26, 2024
Unveiling How Hydroxytyrosol Destabilizes α-Syn Oligomers Using Molecular Simulations
Gagandeep Kaur1, Opinder Kaur Mankoo1, Deepti Goyal2
1Department of Chemistry, Faculty of Basic and Applied Sciences, Sri Guru Granth Sahib World University, Fatehgarh Sahib-140406, Punjab, India.
Hydroxytyrosol (HT) disrupts Parkinson's disease-linked alpha-synuclein (α-Syn) oligomers by altering protein structure. This natural compound offers potential therapeutic strategies for Parkinson's disease by inhibiting toxic protein aggregation.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Parkinson's disease (PD) pathogenesis involves alpha-synuclein (α-Syn) fibrillogenesis.
- Hydroxytyrosol (HT), a polyphenol from olive oil, exhibits neuroprotective effects.
- HT's mechanism in destabilizing α-Syn oligomers and reducing PD cytotoxicity is unclear.
Purpose of the Study:
- To investigate the molecular mechanism of HT in destabilizing α-Syn oligomers.
- To examine the impact of HT on α-Syn oligomer structure and binding.
- To explore HT's potential as a therapeutic agent for PD.
Main Methods:
- Molecular dynamics (MD) simulations were employed to analyze HT-α-Syn interactions.
- Secondary structure analysis assessed changes in α-Syn conformation.
- Binding free energy calculations quantified HT's affinity for α-Syn trimers.
Main Results:
- HT significantly reduced β-sheet content and increased coil content in α-Syn trimers.
- HT formed hydrogen bonds with α-Syn, weakening interchain interactions and disrupting oligomers.
- Favorable binding free energy (ΔGbinding = -23.25 ± 7.86 kcal/mol) confirmed HT's destabilizing effect on α-Syn trimers.
Conclusions:
- HT destabilizes α-Syn oligomers by altering secondary structure and weakening interchain interactions.
- These findings provide mechanistic insights into HT's neuroprotective effects against PD.
- HT demonstrates potential as a therapeutic strategy for disrupting α-Syn aggregation in Parkinson's disease.
More Related Videos
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
07:56Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
Published on: May 30, 2021